금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Stocks Rise Pre-Bell as Traders Await Fed Policy Decision, Inflation Report, Big Tech Earnings
The benchmark US stock measures pointed higher before the opening bell Monday as traders gear up for...
Stock market today: Dow, S&P 500, Nasdaq futures rise ahead of busy week of earnings, Fed rate decision
Investors braced for a full earnings docket and the Federal Reserve's next policy decision this week...
British Pound: Stronger PMIs lean hawkish for BoE – Danske Bank
Danske Research Team notes UK flash PMIs strengthened in October, with the composite rising to 53.1 ...
3 Reasons Investors Watch S&P Global (SPGI)
Over the past six months, S&P Global’s shares (currently trading at $414.07) have posted a disappointing 19.2% loss, well below the S&P 500’s 9.3% gain. This may have investors wondering how to approa ...
Greenbrier downgraded at Susquehanna on low railcar orders
AUD/USD Price Forecast: Bearish bias persists below 0.7000
The Australian Dollar (AUD) trades on the front foot against the US Dollar (USD) on Thursday as a weaker-than-expected US Nonfarm Payrolls (NFP) report pushed back expectations of an imminent Federal ...
Equity Markets Mixed Intraday After Jobs Report
US benchmark equity indexes were mixed intraday as traders assessed the latest jobs report. The N
Novartis gene therapy Itvisma approved in EU for spinal muscular atrophy
Crude Oil forgets the war and shrugs at the tollbooth
Crude Oil finished Thursday at its lowest level in 18 weeks, which means the vast risk premium that built up around this year's conflict has fully bled away, back to pre-war levels.
Western Alliance stock falls after Jefferies sues over First Brands debacle
Concerts are increasingly for superfans and the rich, analysts say
Some arenas are devoting nearly a third of their space to premium seats and services.
Oil prices are now back to prewar levels, but the market is not. Here’s what could happen next.
Oil prices have finally fallen back to pre-Iran war levels — but the crude market is far from seeing a normalization of shipping, oil supplies and demand that such a big retreat implies.
Veracyte Stock Surges 117% in a Year: What's Driving the Rally?
VCYT's 117% stock surge is driven by durable growth plans, Afirma demand, TrueMRD progress, international IVD efforts and a debt-free balance sheet.
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon's new platforms, lenses and dry eye momentum support growth, but macro pressures, tariffs and fierce competition weigh on its outlook.
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now
McKesson's growth in specialty pharma, oncology services and tech-driven solutions is boosting earnings, but policy and execution risks remain in focus.